Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4453279 | 0.89 | TAAR1 (0.35) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| SCHEMBL30096500 | 0.89 | TAAR1 (0.35) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| SCHEMBL18287337 | 0.86 | UGT2B7 (0.32) | — | |
| SCHEMBL18287328 | 0.80 | TAAR1 (0.30) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| SCHEMBL18287324 | 0.78 | UGT2B7 (0.35) | CYP2A6 | |
| SCHEMBL18287341 | 0.76 | ALOX5 (0.34) | MAOA | |
| SCHEMBL7561832 | 0.75 | TSHR (0.43) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| SCHEMBL16632444 | 0.75 | GABRA1 (0.36) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| SCHEMBL28579756 | 0.75 | CYP3A4 (0.46) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| SCHEMBL18287326 | 0.75 | TDP1 (0.46) | SLC6A2TAAR1MAOASLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160359126-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-12-08 | — | — | US | disclosed |
| US-20160359126-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-12-08 | — | — | US | disclosed |
| US-20160359126-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160359126-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | OXA1L, MAL2, L1CAM | SLC6A2 2212/4885TAAR1 4436/4885MAOA 2747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.